Financhill
Back

Apellis Pharmaceuticals Vs. Rocket Pharmaceuticals Industry Stock Comparison

Sell
27

APLS
Apellis Pharmaceuticals

Last Price:
35.74
Seasonality Move:
15.53%
Sell
45

RCKT
Rocket Pharmaceuticals

Last Price:
19.41
Seasonality Move:
40.59%
Sell
27
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $37.62. The Score for APLS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Rocket Pharmaceuticals (RCKT) is a Sell

Is Rocket Pharmaceuticals a Buy, Sell or Hold?

  • The current Rocket Pharmaceuticals [RCKT] share price is $19.65. The Score for RCKT is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • RCKT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $37.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight buying pressure.

RCKT Stock Price Chart

What is Rocket Pharmaceuticals's stock price today?

  • The Rocket Pharmaceuticals share price today is $19.65
    The current trend is relatively stagnant and RCKT is experiencing slight buying pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 46.63 Sell
Chaikin Money Flow: 246806 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.06 - 39.78) Sell
Bollinger Bands (100): (36.75 - 43.51) Sell

RCKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.35 Sell
Relative Strength Index (14 RSI): 51.46 Buy
Chaikin Money Flow: 97337 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.4 - 19.46) Buy
Bollinger Bands (100): (19.55 - 23.45) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.76 Sell
20-day SMA: 38.9 Sell
50-day SMA: 38.09 Sell
200-day SMA: 50.5 Sell
8-day EMA: 38.4 Sell
20-day EMA: 38.51 Sell
50-day EMA: 38.9 Sell
200-day EMA: 46.23 Sell

RCKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.99 Buy
20-day SMA: 18.96 Buy
50-day SMA: 20.72 Sell
200-day SMA: 24.48 Sell
8-day EMA: 19.13 Buy
20-day EMA: 19.23 Buy
50-day EMA: 20.24 Sell
200-day EMA: 22.29 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.24 per share, an increase this year of $3.17 per share, and an increase next year of $1.50 per share.

Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.04 per share, an increase this year of $0.16 per share, and an increase next year of $0.25 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rocket Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):